Skip to main content
OpenTrials
Completed

NCT Number: NCT02690597

Validation and Pertinence of Anxiety Analogic Visual Scale in Pain Management

Screening of anxiogenic part of pain is an imperative during a medical pain consultation. The actual tools for evaluation of this specific part are complex and time consuming.

To date, it lacked a reliable and reproductive tool to quickly evaluate anxiety of patient in pain. The purpose of this study is to demonstrate the pertinence and validity of anxiety analogic visual scale by comparison with the actual reference the self-assessment questionnaire State Trait Inventory Anxiety Y-A form.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anxiety Anxiety Disorders Mental Disorders Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Rangueil

Toulouse, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed and dated informed consent
  • Male or female aged from ≥ 18 years old
  • Perfect patient ability to understand and write French
  • Patient with a pain threshold permitting a initial medication free consultation and completion of anxiety surveys.

Exclusion criteria

  • Inability of patient to understand the study procedures and thus inability to give informed consent.

Treatment and study plan

Anxiety visual analog scale

Other

Anxiety visual analog scale is a test of evaluation of anxiety done by the patient, this scale do not include number and the patient have to place a coloured marker at the level indicating his anxiety feeling

Primary outcomes

  1. Evaluation of pertinence of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

  2. Evaluation of validity of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

  3. Evaluation of pertinence of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with anxiety analogic visual scale score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

  4. Evaluation of validity of anxiety analogic visual scale in systematic use as assessed by anxiety levels obtained with anxiety analogic visual scale score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

Secondary outcomes

  1. Evaluation of pain consultation impact on anxiety part of pain as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

  2. Evaluation of pain consultation impact on anxiety part of pain as assessed by anxiety levels obtained with anxiety analogic visual scale score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

  3. Evaluation of clinical utility of anxiety analogic visual scale in nursing care as assessed by anxiety levels obtained with State Trait of anxiety Y-A form score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

  4. Evaluation of clinical utility of anxiety analogic visual scale in nursing care as assessed by anxiety levels anxiety analogic visual scale score

    Time frame: Baseline

    The patient's inclusion take place during the only study participation day of the patient

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Validation and Pertinence of Anxiety Analogic Visual Scale in Pain Management by Mobile Acute Pain Team

Acronym: ANXYDOL

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Feb 24, 2016
Registry last updated
Dec 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.